A pilot trial of quetiapine for the treatment of patients with delirium
Version of Record online: 3 FEB 2004
Copyright © 2004 John Wiley & Sons, Ltd.
Human Psychopharmacology: Clinical and Experimental
Volume 19, Issue 2, pages 125–127, March 2004
How to Cite
Pae, C.-U., Lee, S.-J., Lee, C.-U., Lee, C. and Paik, I.-H. (2004), A pilot trial of quetiapine for the treatment of patients with delirium. Hum. Psychopharmacol. Clin. Exp., 19: 125–127. doi: 10.1002/hup.559
- Issue online: 18 FEB 2004
- Version of Record online: 3 FEB 2004
- Manuscript Accepted: 7 NOV 2003
- Manuscript Received: 13 OCT 2003
- AstraZeneca Korea
- delirium rating scale-revised-98;
- clinical global impression scale;
Twenty-two Korean inpatients with delirium were administered prospectively a flexible dose of quetiapine. The delirium rating scale-revised-severity 98 (DRS-R-98) and clinical global impression scale-severity (CGI-s) scores were assessed at the time of pre- and post-treatment. The DRS-R-98 and CGI-s scores were significantly reduced by 57.3% and 55.1%, respectively. Quetiapine was effective and safe for the treatment of patients with delirium, and could be a useful alternative agent to classical antipsychotics in the treatment of delirium. Copyright © 2004 John Wiley & Sons, Ltd.